Bispecific T-Cell Engagers Market Set to Reach $4.18 Billion by 2030, Driven by Technological Advancements and Growing Healthcare Investments.
ByAinvest
Friday, Mar 27, 2026 11:18 am ET1min read
KMX--
Kahn Swick & Foti, LLC is investigating CarMax, Inc. (KMX) regarding its second quarter Fiscal Year 2026 financial results, which disclosed a decrease in retail unit sales, net earnings, and the unexpected departure of its CEO. The investigation is focused on whether CarMax's officers and directors breached their fiduciary duties to shareholders or violated state or federal laws. If you have information that could assist the investigation or were a long-term holder of CarMax shares, you may contact the firm for more information.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet